“Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s299. Accessed May 22, 2026. https://skin.dermsquared.com/skin/article/view/2367.